Author

S. Kerrigan

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2

Frequent Co-Authors

A. Kissenpfennig· 1 shared A. Short· 1 shared A. Yakkundi· 1 shared C. Campbell· 1 shared C. Drakeford· 1 shared C. Garciarena· 1 shared D. Nader· 1 shared D. Sharpe· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Kissenpfennig

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Vascular dysregulation following SARS-CoV-2 infection involves integrin signaling through a VE-Cadherin mediated pathway

D. Nader, S. Kerrigan

This study identifies integrin Vβ3 as a receptor for SARS-CoV-2 spike protein through its RGD motif, leading to vascular barrier disruption via VE-Cadherin internalization.

bioRxiv · Mar 15, 2022 · PreprintMicrobiology

The immunophilin protein FKBPL and its peptide derivatives are novel regulators of vascular integrity and inflammation via NF-kappaB signaling

S. L. Annett, S. Spence, C. Garciarena, C. Campbell, M. Dennehy, C. Drakeford, J. Lai, J. Dowling, G. Moore, A. Yakkundi, A. Short, D. Sharpe, F. Furlong, J. O'Donnell, G. Cavalleri, , T. Robson

This paper identifies FKBPL and its peptides as regulators of vascular integrity and inflammation via NF-kappaB signaling, showing therapeutic potential in inflammatory diseases.

bioRxiv · Feb 24, 2021 · PreprintImmunology